Y.D. More Investments Ltd Boosts Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Y.D. More Investments Ltd increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 14.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,072 shares of the healthcare conglomerate’s stock after buying an additional 260 shares during the period. Y.D. More Investments Ltd’s holdings in UnitedHealth Group were worth $1,091,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. Bensler LLC lifted its stake in UnitedHealth Group by 0.3% during the 3rd quarter. Bensler LLC now owns 7,293 shares of the healthcare conglomerate’s stock valued at $3,677,000 after acquiring an additional 19 shares during the period. Texas Capital Bancshares Inc TX grew its holdings in UnitedHealth Group by 1.1% during the 3rd quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock valued at $855,000 after buying an additional 19 shares in the last quarter. Tealwood Asset Management Inc. grew its holdings in UnitedHealth Group by 0.4% during the 4th quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate’s stock valued at $2,626,000 after buying an additional 19 shares in the last quarter. Atlas Private Wealth Advisors lifted its position in shares of UnitedHealth Group by 1.1% during the fourth quarter. Atlas Private Wealth Advisors now owns 1,752 shares of the healthcare conglomerate’s stock worth $923,000 after purchasing an additional 19 shares during the last quarter. Finally, Prentice Wealth Management LLC lifted its position in shares of UnitedHealth Group by 0.8% during the fourth quarter. Prentice Wealth Management LLC now owns 2,347 shares of the healthcare conglomerate’s stock worth $1,235,000 after purchasing an additional 19 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which is available at this link. In other news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on UNH. Barclays raised their price target on UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research note on Wednesday, April 17th. Deutsche Bank Aktiengesellschaft lifted their target price on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a report on Friday, April 19th. HSBC raised UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price target for the company in a report on Thursday, April 4th. Oppenheimer reissued an “outperform” rating and issued a $610.00 price target on shares of UnitedHealth Group in a report on Wednesday, January 17th. Finally, Truist Financial restated a “buy” rating and issued a $600.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, April 17th. Four analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $570.05.

UnitedHealth Group Stock Up 0.1 %

UNH stock traded up $0.41 during mid-day trading on Wednesday, reaching $484.11. The company had a trading volume of 2,623,949 shares, compared to its average volume of 4,444,622. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70. The company has a market capitalization of $445.42 billion, a price-to-earnings ratio of 29.74, a price-to-earnings-growth ratio of 1.42 and a beta of 0.54. The firm has a fifty day simple moving average of $484.44 and a 200 day simple moving average of $513.42.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same quarter last year, the company earned $6.26 EPS. The business’s quarterly revenue was up 8.6% on a year-over-year basis. Analysts forecast that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were paid a $1.88 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.55%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 45.97%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.